Logo

U of Texas to Use DNAStar's Software for Clinical Research Applications

Nov 12, 2011
Premium

DNAStar said this week that the University of Texas Medical Branch, the healthcare arm of the University of Texas System, has purchased licenses for its Lasergene and ArrayStar software packages and plans to use the tools in clinical research applications.

DNAStar said that researchers in UTMB's pathology research laboratories will use its software to analyze genomic sequence data.

DNAStar's Lasergene suite is comprised of eight applications for analyzing DNA and protein sequences. It includes tools for sequence assembly, single nucleotide polymorphism detection, virtual cloning, and primer design, among others. ArrayStar provides algorithms for analyzing gene expression data and identifying sequence variation.

The financial terms of the licensing arrangement were not disclosed.

Filed under

Informatics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.